新兴的抗炎性COPD治疗方法:潜在的心血管影响
Mario Cazzola1, Luigino Calzetta2, Paola Rogliani1
1Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'tor Vergata', Rome, Italy.
International journal of chronic obstructive pulmonary disease
|November 28, 2024
概括
慢性阻塞性肺病 (COPD) 的新兴抗炎疗法显示出多种心血管影响. 在患有心血管疾病 (CVD) 的COPD患者中,对固醇酶抑制剂,p38 MAPK,PI3K抑制剂和生物药物进行仔细监测至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 经常与心血管疾病 (CVD) 一起发生,这是由于共同的炎症过程.
- 新兴的COPD抗炎疗法具有复杂的心血管影响.
- 了解这些相互作用对于患者管理至关重要.
研究的目的:
- 审查用于COPD管理的新型抗炎疗法对心血管的影响.
- 评估这些疗法在患有并发性心血管疾病的患者中的潜在益处和风险.
主要方法:
- 对COPD新兴抗炎疗法的文献综述.
- 对心血管影响的分析,包括对炎症,内皮功能,血栓形成,心脏纤维化和心律不整的影响.
- 评估特定药物类别:PDE抑制剂,p38 MAPK抑制剂,PI3K抑制剂,生物制剂,中性粒细胞弹性酶/MMP抑制剂和α-1抗素.
主要成果:
- PDE4 抑制剂可能会减少心血管事件,而 PDE3 抑制剂可能会导致心律失常.
- p38 MAPK和PI3K抑制剂通过减少心脏纤维化和改善收缩性显示出潜在的益处.
- 由于免疫调节作用,生物药物需要进行心血管监测;单位抑制剂具有混合的心血管特征;α-1抗素可能提供心脏保护.
结论:
- 创新的COPD疗法对心血管有不同的影响,因此需要在患有心血管疾病的COPD患者中进行早期评估.
- 在不同的治疗类别中,风险效益概况在不同治疗类别中存在显著差异.
- 密切监测和进一步的研究对于优化并发性COPD和CVD的治疗策略至关重要.
更多相关视频
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
179
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
179
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
352
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
352
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:20COPD: Pathogenesis and Clinical Features
233
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
233
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K